R. Cardnell

Dual Inhibition of MEK and AXL Targets Tumor Cell Heterogeneity and Prevents Resistant Outgrowth Mediated by the Epithelial-to-Mesenchymal Transition in NSCLC

Jing Wang, J. Konen, L. Byers, 2021, Cancer Research.

Adapting Nanopore Sequencing Basecalling Models for Modification Detection via Incremental Learning and Anomaly Detection

Y. Xi, L. Byers, D. Gibbons, 2023, bioRxiv.

STING pathway expression identifies non-small cell lung cancers with an immune-responsive phenotype.

Jing Wang, I. Wistuba, C. Behrens, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

STING pathway expression identifies non-small cell lung cancers with an immune-responsive phenotype

C. Behrens, J. Fujimoto, L. Byers, 2020 .

Combination treatment of the oral CHK1 inhibitor, SRA737 and low dose gemcitabine, enhances the effect of PD-L1 blockade by modulating the immune microenvironment in small cell lung cancer.

Jing Wang, L. Byers, M. Hedrick, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Combination treatment of the oral CHK1 inhibitor, SRA737 and low dose gemcitabine, enhances the effect of PD-L1 blockade by modulating the immune microenvironment in small cell lung cancer.

L. Byers, C. Gay, T. Sen, 2020 .